Skip directly to content

We Are Pfizer

Pfizer has operated in New Zealand since 1961 when its office first opened in Auckland.

In this time Pfizer has contributed significantly to improving the health of Kiwis through a wide-ranging health portfolio, in addition to positively impacting New Zealand’s economic and workforce development.

We are committed to New Zealand and have invested heavily in innovation and research to support the development of new medicines and given back to the community through new partnerships and philanthropic ventures.

Recent disease areas being studied in New Zealand include: Cardiovascular, Inflammation, Gastrointestinal, Metabolic diseases, Haematology, Oncology and Pain.